ZIPORA MARTIN-BROWN: Open Payments
NPI 1912471939 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$46 in 3 payments from 2 companies in 2025. Trend: 2023 $62 · 2024 $203 · 2025 $46
Food & beverage: $46
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Ozempic, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
